IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
Por um escritor misterioso
Descrição
Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency: Cell
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
IJMS, Free Full-Text
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
Engineering of bispecific antibodies. a, Schematic diagram of
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
Antibodies, Free Full-Text
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant, One Health Advances
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant, One Health Advances
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses - ScienceDirect
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
